The nNGM (national Network Genomic Medicine lung cancer) demands the detection of defined areas including variant hot spots in 26 Genes (ALK, BRAF, CTNNB1, EGFR, ERBB2, FGFR1, FGFR2, FGFR3, FGFR4, HRAS, IDH1, IDH2, KEAP1, KRAS, MAP2K1, MET, NRAS, NTRK1, NTRK2, NTRK3, PIK3CA, PTEN, RET, ROS1, STK11, TP53). This evidence concerns the gene MET and lung carcinoma.